查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1457951

全球外科手術市場：市場規模和佔有率分析（依類型、提供者、性別和年齡層）、行業需求預測（截至 2030 年）

Surgical Procedures Market Size and Share Analysis by Type, Provider, Gender, Age Group - Global Industry Demand Forecast to 2030
出版日期: | 出版商: Prescient & Strategic Intelligence | 英文 260 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

全球外科手術市場正以 3.3% 的複合年增長率擴張，到 2023 年將達到 1.1 億例，到 2030 年將達到 1.375 億例。

造成此現象的主要原因是慢性病，特別是癌症和心血管疾病的發生率迅速上升，加上人口老化。

北美引領市場

2023 年，北美市佔率最大，達 50%。 這是由於發達的醫療保健系統的存在，以及心臟病、骨科疾病和胃腸道疾病等疾病盛行率的增加。

亞太地區未來幾年將以最快的速度成長，約3.5%。 這是由於人們對慢性病的認識不斷提高、外科技術的發展、神經系統疾病和創傷發病率的增加以及醫療和醫療旅遊部門的興起。

依細分市場的見解

2023年，婦產科品類比最大，佔約30%。 這是由於多囊性卵巢症候群（PCOS）、子宮內膜異位症、卵巢囊腫、慢性骨盆腔疼痛、卵巢和子宮癌、骨盆腔發炎、子宮肌瘤、子宮肌腺症等婦科疾病的發生率不斷增加所致。

另一方面，眼科領域預計未來幾年將以最快約3.7%的速度發展。 這主要是由於青光眼、糖尿病視網膜病變、白內障等各種眼部疾病的發生率不斷增加。

到 2023 年，醫院將成為最大的最終用戶類別，約佔 45% 的佔有率，並將在這十年中保持最大的地位。 這是由於全世界這些醫療機構進行的手術數量龐大以及各種慢性病的盛行率不斷增加。

本報告分析了全球外科市場，包括市場的基本結構和最新情況、主要促進和限制因素以及全球、依地區和主要國家的市場規模前景（病例數、金額（2017-2030）、依類型、提供者、性別和年齡組別劃分的詳細趨勢、市場競爭現狀以及主要公司概況。

目錄

第一章研究範圍

第二章研究方法

第 3 章執行摘要

第 4 章市場指標

第五章產業展望

  • 市場動態
    • 趨勢
    • 促進因素
    • 抑制因素/課題
    • 促進/抑制因子影響分析
  • 新型冠狀病毒感染 (COVID-19) 的影響
  • 波特五力分析

第六章世界市場

  • 摘要
  • 市場規模：依類型劃分（2017-2030 年）
  • 市場收入：依類型劃分（2017-2030 年）
  • 市場規模：依供應商劃分（2017-2030 年）
  • 市場收入：依提供者劃分（2017-2030 年）
  • 市場規模：依性別劃分（2017-2030 年）
  • 市場收入：依性別劃分（2017-2030 年）
  • 市場規模：依年齡層劃分（2017-2030 年）
  • 市場收入：依年齡層劃分（2017-2030 年）
  • 市場規模：依地區劃分（2017-2030 年）
  • 市場收入：依地區劃分（2017-2030 年）

第七章北美市場

  • 摘要
  • 市場規模：依類型劃分（2017-2030 年）
  • 市場收入：依類型劃分（2017-2030 年）
  • 市場規模：依供應商劃分（2017-2030 年）
  • 市場收入：依提供者劃分（2017-2030 年）
  • 市場規模：依性別劃分（2017-2030 年）
  • 市場收入：依性別劃分（2017-2030 年）
  • 市場規模：依年齡層劃分（2017-2030 年）
  • 市場收入：依年齡層劃分（2017-2030 年）
  • 市場規模：依國家劃分（2017-2030 年）
  • 市場收入：依國家/地區劃分（2017-2030 年）

第8章歐洲市場

第9章亞太市場

第10章拉丁美洲市場

第 11 章中東與非洲 (MEA) 市場

第12章美國市場

  • 摘要
  • 市場規模：依類型劃分（2017-2030 年）
  • 市場收入：依類型劃分（2017-2030 年）
  • 市場規模：依供應商劃分（2017-2030 年）
  • 市場收入：依提供者劃分（2017-2030 年）
  • 市場規模：依性別劃分（2017-2030 年）
  • 市場收入：依性別劃分（2017-2030 年）
  • 市場規模：依年齡層劃分（2017-2030 年）
  • 市場收入：依年齡層劃分（2017-2030 年）

第十三章加拿大市場

第14章德國市場

第十五章法國市場

第十六章英國市場

第十七章義大利市場

第十八章西班牙市場

第十九章日本市場

第20章中國市場

第21章印度市場

第22章澳洲市場

第23章韓國市場

第24章巴西市場

第25章墨西哥市場

第26章沙烏地阿拉伯市場

第27章南非市場

第 28 章阿聯酋 (UAE) 市場

第29章競爭態勢

  • 市場參與者及其提供的產品/服務的列表
  • 主要公司的競爭基準
  • 各大公司的產品基準
  • 近期策略發展狀況

第30章公司簡介

  • Stryker Corporation
  • Becton, Dickinson and Company
  • Olympus Corporation
  • Zimmer Biomet
  • Abbott Laboratories
  • Boston Scientific Corporation
  • Smith & Nephew
  • Medtronic plc
  • Cook Medical
  • CONMED Corporation

第31章附錄

簡介目錄
Product Code: 12799

The surgical procedures market was 110.0 million procedures in 2023, and it will increase to 137.5 million, advancing at a 3.3% compound annual growth rate, by 2030.

This is mainly because of the surging incidence of chronic disorders, particularly cancer and CVDs; coupled with the increasing elderly population.

Aging people are more vulnerable to chronic ailments like diabetes, cancer, cardiovascular diseases, and neurological disorders, which led to the growing need for surgical procedures. Likewise, the low levels of immunity make the elderly population more susceptible to infections, therefore resulting in an increase in the number of surgical procedures.

As per the World Health Organization, there were an estimated 20 million new cases of cancer and 9.7 million deaths in 2022.

The projected number of individuals who were alive within 5 years following a cancer diagnosis was 53.5 million.

Approximately 1 out of 5 people develop cancer in their lifetime, around 1 out of 12 women and 1 out of 9 men die from the ailment.

Moreover, as per a report, worldwide death counts because of CVD increase to 19.8 million in 2022 from 12.4 million in 1990 reflecting worldwide population growth as well as aging.

Furthermore, the technological improvements in the surgical process will further assist the growth of this industry in the years to come.

The high count of outpatient surgeries is offering significant growth opportunities to the industry. Outpatient surgeries do not mandate an overnight stay at the hospital. Currently, medical procedures are increasing at outpatient facilities due to technological improvements, counting the arrival of minimally invasive surgeries, and the accessibility of value-based care incentives.

North America is Leading Market

North America accounted for the largest share of the industry in 2023, of 50%. This is because of the existence of developed healthcare systems, along with the rising incidence of diseases like cardiac, orthopedic, and gastrointestinal disorders.

Moreover, the higher acceptance rate of cutting-edge devices as well as the change in the fondness toward outpatient surgeries are also aiding the regional industry growth.

APAC will advance at the fastest rate of approximately 3.5% in the coming years. This is because of the rising consciousness of chronic disorders, the arrival of developed surgical technologies, the increasing incidence of neurological disorders and traumatic injuries, and the flourishing healthcare and medical tourism sectors, in this region.

Segmentation Insights

The obstetric & gynecological category was the largest contributor to the industry in 2023, with approximately 30% share. This is ascribed to the increasing incidence of gynecological disorders, including polycystic ovary syndrome (PCOS), endometriosis, ovarian cysts, chronic pelvic pain, ovarian and uterine cancer, pelvic inflammatory disease, uterine fibroids, and adenomyosis.

Whereas, the ophthalmic category will advance at the fastest rate, of approximately 3.7%, in the years to come. This can be mainly because of the increasing occurrence of various ophthalmic disorders, such as glaucoma, diabetic retinopathy, and cataracts.

The hospital was the largest end user category in 2023, with approximately 45% share, and it will remain the largest throughout this decade. This is because of the high count of surgeries carried out in these healthcare settings globally; and the rising prevalence of various chronic ailments.

With the surging occurrence of chronic diseases across the globe, the need for surgical procedures will continue to increase in the years to come.

Table of Contents

Chapter 1. Research Scope

  • 1.1. Research Objectives
  • 1.2. Market Definition
  • 1.3. Analysis Period
  • 1.4. Market Size Breakdown by Segments
    • 1.4.1. Market size breakdown, by type
    • 1.4.2. Market size breakdown, by provider
    • 1.4.3. Market size breakdown, by gender
    • 1.4.4. Market size breakdown, by age group
    • 1.4.5. Market size breakdown, by region
    • 1.4.6. Market size breakdown, by country
  • 1.5. Market Data Reporting Unit
    • 1.5.1. Volume
    • 1.5.2. Value
  • 1.6. Key Stakeholders

Chapter 2. Research Methodology

  • 2.1. Secondary Research
    • 2.1.1. Paid
    • 2.1.2. Unpaid
    • 2.1.3. P&S Intelligence database
  • 2.2. Primary Research
  • 2.3. Market Size Estimation
  • 2.4. Data Triangulation
  • 2.5. Currency Conversion Rates
  • 2.6. Assumptions for the Study
  • 2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

  • 5.1. Market Dynamics
    • 5.1.1. Trends
    • 5.1.2. Drivers
    • 5.1.3. Restraints/challenges
    • 5.1.4. Impact analysis of drivers/restraints
  • 5.2. Impact of COVID-19
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Bargaining power of buyers
    • 5.3.2. Bargaining power of suppliers
    • 5.3.3. Threat of new entrants
    • 5.3.4. Intensity of rivalry
    • 5.3.5. Threat of substitutes

Chapter 6. Global Market

  • 6.1. Overview
  • 6.2. Market Volume, by Type (2017-2030)
  • 6.3. Market Revenue, by Type (2017-2030)
  • 6.4. Market Volume, by Provider (2017-2030)
  • 6.5. Market Revenue, by Provider (2017-2030)
  • 6.6. Market Volume, by Gender (2017-2030)
  • 6.7. Market Revenue, by Gender (2017-2030)
  • 6.8. Market Volume, by Age Group (2017-2030)
  • 6.9. Market Revenue, by Age Group (2017-2030)
  • 6.10. Market Volume, by Region (2017-2030)
  • 6.11. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

  • 7.1. Overview
  • 7.2. Market Volume, by Type (2017-2030)
  • 7.3. Market Revenue, by Type (2017-2030)
  • 7.4. Market Volume, by Provider (2017-2030)
  • 7.5. Market Revenue, by Provider (2017-2030)
  • 7.6. Market Volume, by Gender (2017-2030)
  • 7.7. Market Revenue, by Gender (2017-2030)
  • 7.8. Market Volume, by Age Group (2017-2030)
  • 7.9. Market Revenue, by Age Group (2017-2030)
  • 7.10. Market Volume, by Country (2017-2030)
  • 7.11. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

  • 8.1. Overview
  • 8.2. Market Volume, by Type (2017-2030)
  • 8.3. Market Revenue, by Type (2017-2030)
  • 8.4. Market Volume, by Provider (2017-2030)
  • 8.5. Market Revenue, by Provider (2017-2030)
  • 8.6. Market Volume, by Gender (2017-2030)
  • 8.7. Market Revenue, by Gender (2017-2030)
  • 8.8. Market Volume, by Age Group (2017-2030)
  • 8.9. Market Revenue, by Age Group (2017-2030)
  • 8.10. Market Volume, by Country (2017-2030)
  • 8.11. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

  • 9.1. Overview
  • 9.2. Market Volume, by Type (2017-2030)
  • 9.3. Market Revenue, by Type (2017-2030)
  • 9.4. Market Volume, by Provider (2017-2030)
  • 9.5. Market Revenue, by Provider (2017-2030)
  • 9.6. Market Volume, by Gender (2017-2030)
  • 9.7. Market Revenue, by Gender (2017-2030)
  • 9.8. Market Volume, by Age Group (2017-2030)
  • 9.9. Market Revenue, by Age Group (2017-2030)
  • 9.10. Market Volume, by Country (2017-2030)
  • 9.11. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

  • 10.1. Overview
  • 10.2. Market Volume, by Type (2017-2030)
  • 10.3. Market Revenue, by Type (2017-2030)
  • 10.4. Market Volume, by Provider (2017-2030)
  • 10.5. Market Revenue, by Provider (2017-2030)
  • 10.6. Market Volume, by Gender (2017-2030)
  • 10.7. Market Revenue, by Gender (2017-2030)
  • 10.8. Market Volume, by Age Group (2017-2030)
  • 10.9. Market Revenue, by Age Group (2017-2030)
  • 10.10. Market Volume, by Country (2017-2030)
  • 10.11. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

  • 11.1. Overview
  • 11.2. Market Volume, by Type (2017-2030)
  • 11.3. Market Revenue, by Type (2017-2030)
  • 11.4. Market Volume, by Provider (2017-2030)
  • 11.5. Market Revenue, by Provider (2017-2030)
  • 11.6. Market Volume, by Gender (2017-2030)
  • 11.7. Market Revenue, by Gender (2017-2030)
  • 11.8. Market Volume, by Age Group (2017-2030)
  • 11.9. Market Revenue, by Age Group (2017-2030)
  • 11.10. Market Volume, by Country (2017-2030)
  • 11.11. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

  • 12.1. Overview
  • 12.2. Market Volume, by Type (2017-2030)
  • 12.3. Market Revenue, by Type (2017-2030)
  • 12.4. Market Volume, by Provider (2017-2030)
  • 12.5. Market Revenue, by Provider (2017-2030)
  • 12.6. Market Volume, by Gender (2017-2030)
  • 12.7. Market Revenue, by Gender (2017-2030)
  • 12.8. Market Volume, by Age Group (2017-2030)
  • 12.9. Market Revenue, by Age Group (2017-2030)

Chapter 13. Canada Market

  • 13.1. Overview
  • 13.2. Market Volume, by Type (2017-2030)
  • 13.3. Market Revenue, by Type (2017-2030)
  • 13.4. Market Volume, by Provider (2017-2030)
  • 13.5. Market Revenue, by Provider (2017-2030)
  • 13.6. Market Volume, by Gender (2017-2030)
  • 13.7. Market Revenue, by Gender (2017-2030)
  • 13.8. Market Volume, by Age Group (2017-2030)
  • 13.9. Market Revenue, by Age Group (2017-2030)

Chapter 14. Germany Market

  • 14.1. Overview
  • 14.2. Market Volume, by Type (2017-2030)
  • 14.3. Market Revenue, by Type (2017-2030)
  • 14.4. Market Volume, by Provider (2017-2030)
  • 14.5. Market Revenue, by Provider (2017-2030)
  • 14.6. Market Volume, by Gender (2017-2030)
  • 14.7. Market Revenue, by Gender (2017-2030)
  • 14.8. Market Volume, by Age Group (2017-2030)
  • 14.9. Market Revenue, by Age Group (2017-2030)

Chapter 15. France Market

  • 15.1. Overview
  • 15.2. Market Volume, by Type (2017-2030)
  • 15.3. Market Revenue, by Type (2017-2030)
  • 15.4. Market Volume, by Provider (2017-2030)
  • 15.5. Market Revenue, by Provider (2017-2030)
  • 15.6. Market Volume, by Gender (2017-2030)
  • 15.7. Market Revenue, by Gender (2017-2030)
  • 15.8. Market Volume, by Age Group (2017-2030)
  • 15.9. Market Revenue, by Age Group (2017-2030)

Chapter 16. U.K. Market

  • 16.1. Overview
  • 16.2. Market Volume, by Type (2017-2030)
  • 16.3. Market Revenue, by Type (2017-2030)
  • 16.4. Market Volume, by Provider (2017-2030)
  • 16.5. Market Revenue, by Provider (2017-2030)
  • 16.6. Market Volume, by Gender (2017-2030)
  • 16.7. Market Revenue, by Gender (2017-2030)
  • 16.8. Market Volume, by Age Group (2017-2030)
  • 16.9. Market Revenue, by Age Group (2017-2030)

Chapter 17. Italy Market

  • 17.1. Overview
  • 17.2. Market Volume, by Type (2017-2030)
  • 17.3. Market Revenue, by Type (2017-2030)
  • 17.4. Market Volume, by Provider (2017-2030)
  • 17.5. Market Revenue, by Provider (2017-2030)
  • 17.6. Market Volume, by Gender (2017-2030)
  • 17.7. Market Revenue, by Gender (2017-2030)
  • 17.8. Market Volume, by Age Group (2017-2030)
  • 17.9. Market Revenue, by Age Group (2017-2030)

Chapter 18. Spain Market

  • 18.1. Overview
  • 18.2. Market Volume, by Type (2017-2030)
  • 18.3. Market Revenue, by Type (2017-2030)
  • 18.4. Market Volume, by Provider (2017-2030)
  • 18.5. Market Revenue, by Provider (2017-2030)
  • 18.6. Market Volume, by Gender (2017-2030)
  • 18.7. Market Revenue, by Gender (2017-2030)
  • 18.8. Market Volume, by Age Group (2017-2030)
  • 18.9. Market Revenue, by Age Group (2017-2030)

Chapter 19. Japan Market

  • 19.1. Overview
  • 19.2. Market Volume, by Type (2017-2030)
  • 19.3. Market Revenue, by Type (2017-2030)
  • 19.4. Market Volume, by Provider (2017-2030)
  • 19.5. Market Revenue, by Provider (2017-2030)
  • 19.6. Market Volume, by Gender (2017-2030)
  • 19.7. Market Revenue, by Gender (2017-2030)
  • 19.8. Market Volume, by Age Group (2017-2030)
  • 19.9. Market Revenue, by Age Group (2017-2030)

Chapter 20. China Market

  • 20.1. Overview
  • 20.2. Market Volume, by Type (2017-2030)
  • 20.3. Market Revenue, by Type (2017-2030)
  • 20.4. Market Volume, by Provider (2017-2030)
  • 20.5. Market Revenue, by Provider (2017-2030)
  • 20.6. Market Volume, by Gender (2017-2030)
  • 20.7. Market Revenue, by Gender (2017-2030)
  • 20.8. Market Volume, by Age Group (2017-2030)
  • 20.9. Market Revenue, by Age Group (2017-2030)

Chapter 21. India Market

  • 21.1. Overview
  • 21.2. Market Volume, by Type (2017-2030)
  • 21.3. Market Revenue, by Type (2017-2030)
  • 21.4. Market Volume, by Provider (2017-2030)
  • 21.5. Market Revenue, by Provider (2017-2030)
  • 21.6. Market Volume, by Gender (2017-2030)
  • 21.7. Market Revenue, by Gender (2017-2030)
  • 21.8. Market Volume, by Age Group (2017-2030)
  • 21.9. Market Revenue, by Age Group (2017-2030)

Chapter 22. Australia Market

  • 22.1. Overview
  • 22.2. Market Volume, by Type (2017-2030)
  • 22.3. Market Revenue, by Type (2017-2030)
  • 22.4. Market Volume, by Provider (2017-2030)
  • 22.5. Market Revenue, by Provider (2017-2030)
  • 22.6. Market Volume, by Gender (2017-2030)
  • 22.7. Market Revenue, by Gender (2017-2030)
  • 22.8. Market Volume, by Age Group (2017-2030)
  • 22.9. Market Revenue, by Age Group (2017-2030)

Chapter 23. South Korea Market

  • 23.1. Overview
  • 23.2. Market Volume, by Type (2017-2030)
  • 23.3. Market Revenue, by Type (2017-2030)
  • 23.4. Market Volume, by Provider (2017-2030)
  • 23.5. Market Revenue, by Provider (2017-2030)
  • 23.6. Market Volume, by Gender (2017-2030)
  • 23.7. Market Revenue, by Gender (2017-2030)
  • 23.8. Market Volume, by Age Group (2017-2030)
  • 23.9. Market Revenue, by Age Group (2017-2030)

Chapter 24. Brazil Market

  • 24.1. Overview
  • 24.2. Market Volume, by Type (2017-2030)
  • 24.3. Market Revenue, by Type (2017-2030)
  • 24.4. Market Volume, by Provider (2017-2030)
  • 24.5. Market Revenue, by Provider (2017-2030)
  • 24.6. Market Volume, by Gender (2017-2030)
  • 24.7. Market Revenue, by Gender (2017-2030)
  • 24.8. Market Volume, by Age Group (2017-2030)
  • 24.9. Market Revenue, by Age Group (2017-2030)

Chapter 25. Mexico Market

  • 25.1. Overview
  • 25.2. Market Volume, by Type (2017-2030)
  • 25.3. Market Revenue, by Type (2017-2030)
  • 25.4. Market Volume, by Provider (2017-2030)
  • 25.5. Market Revenue, by Provider (2017-2030)
  • 25.6. Market Volume, by Gender (2017-2030)
  • 25.7. Market Revenue, by Gender (2017-2030)
  • 25.8. Market Volume, by Age Group (2017-2030)
  • 25.9. Market Revenue, by Age Group (2017-2030)

Chapter 26. Saudi Arabia Market

  • 26.1. Overview
  • 26.2. Market Volume, by Type (2017-2030)
  • 26.3. Market Revenue, by Type (2017-2030)
  • 26.4. Market Volume, by Provider (2017-2030)
  • 26.5. Market Revenue, by Provider (2017-2030)
  • 26.6. Market Volume, by Gender (2017-2030)
  • 26.7. Market Revenue, by Gender (2017-2030)
  • 26.8. Market Volume, by Age Group (2017-2030)
  • 26.9. Market Revenue, by Age Group (2017-2030)

Chapter 27. South Africa Market

  • 27.1. Overview
  • 27.2. Market Volume, by Type (2017-2030)
  • 27.3. Market Revenue, by Type (2017-2030)
  • 27.4. Market Volume, by Provider (2017-2030)
  • 27.5. Market Revenue, by Provider (2017-2030)
  • 27.6. Market Volume, by Gender (2017-2030)
  • 27.7. Market Revenue, by Gender (2017-2030)
  • 27.8. Market Volume, by Age Group (2017-2030)
  • 27.9. Market Revenue, by Age Group (2017-2030)

Chapter 28. U.A.E. Market

  • 28.1. Overview
  • 28.2. Market Volume, by Type (2017-2030)
  • 28.3. Market Revenue, by Type (2017-2030)
  • 28.4. Market Volume, by Provider (2017-2030)
  • 28.5. Market Revenue, by Provider (2017-2030)
  • 28.6. Market Volume, by Gender (2017-2030)
  • 28.7. Market Revenue, by Gender (2017-2030)
  • 28.8. Market Volume, by Age Group (2017-2030)
  • 28.9. Market Revenue, by Age Group (2017-2030)

Chapter 29. Competitive Landscape

  • 29.1. List of Market Players and their Offerings
  • 29.2. Competitive Benchmarking of Key Players
  • 29.3. Product Benchmarking of Key Players
  • 29.4. Recent Strategic Developments

Chapter 30. Company Profiles

  • 30.1. Stryker Corporation
    • 30.1.1. Business overview
    • 30.1.2. Product and service offerings
    • 30.1.3. Key financial summary
  • 30.2. Becton, Dickinson and Company
    • 30.2.1. Business overview
    • 30.2.2. Product and service offerings
    • 30.2.3. Key financial summary
  • 30.3. Olympus Corporation
    • 30.3.1. Business overview
    • 30.3.2. Product and service offerings
    • 30.3.3. Key financial summary
  • 30.4. Zimmer Biomet
    • 30.4.1. Business overview
    • 30.4.2. Product and service offerings
    • 30.4.3. Key financial summary
  • 30.5. Abbott Laboratories
    • 30.5.1. Business overview
    • 30.5.2. Product and service offerings
    • 30.5.3. Key financial summary
  • 30.6. Boston Scientific Corporation
    • 30.6.1. Business overview
    • 30.6.2. Product and service offerings
    • 30.6.3. Key financial summary
  • 30.7. Smith & Nephew
    • 30.7.1. Business overview
    • 30.7.2. Product and service offerings
    • 30.7.3. Key financial summary
  • 30.8. Medtronic plc
    • 30.8.1. Business overview
    • 30.8.2. Product and service offerings
    • 30.8.3. Key financial summary
  • 30.9. Cook Medical
    • 30.9.1. Business overview
    • 30.9.2. Product and service offerings
    • 30.9.3. Key financial summary
  • 30.10. CONMED Corporation
    • 30.10.1. Business overview
    • 30.10.2. Product and service offerings
    • 30.10.3. Key financial summary

Chapter 31. Appendix

  • 31.1. Abbreviations
  • 31.2. Sources and References
  • 31.3. Related Reports